Intravenous Thrombolysis in Expanded Time Window (3-4.5 hours) in General Practice with Concurrent Availability of Endovascular Treatment

INTRODUCTION: A randomized double-blind trial (ECASS III) demonstrated that intravenous (IV) recombinant tissue plasminogen activator (rt-PA) administered between 3 and 4.5 hrs after the onset of symptoms significantly improved clinical outcomes in patients with acute ischemic stroke. In May 2009, t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tekle, Wondwossen G, Chaudhry, Saqib A, Fatima, Zara, Ahmed, Maryam, Khalil, Shujaat, Hassan, Ameer E, Rodriguez, Gustavo J, Suri, Fareed K, Qureshi, Adnan I
Formato: Artigo
Idioma:Inglês
Publicado em: Zeenat Qureshi Stroke Research Center 2012
Assuntos:
Original Contribution
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3379904/
https://ncbi.nlm.nih.gov/pubmed/22737262
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados